Beijing Wandong Medical Technology Co.,Ltd.

SHSE:600055 Stock Report

Market Cap: CN¥12.0b

Beijing Wandong Medical TechnologyLtd Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Beijing Wandong Medical TechnologyLtd.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth26.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

There's Reason For Concern Over Beijing Wandong Medical Technology Co.,Ltd.'s (SHSE:600055) Massive 28% Price Jump

Nov 12
There's Reason For Concern Over Beijing Wandong Medical Technology Co.,Ltd.'s (SHSE:600055) Massive 28% Price Jump

Returns On Capital At Beijing Wandong Medical TechnologyLtd (SHSE:600055) Paint A Concerning Picture

Oct 23
Returns On Capital At Beijing Wandong Medical TechnologyLtd (SHSE:600055) Paint A Concerning Picture

Beijing Wandong Medical Technology Co.,Ltd.'s (SHSE:600055) Price Is Out Of Tune With Earnings

Sep 26
Beijing Wandong Medical Technology Co.,Ltd.'s (SHSE:600055) Price Is Out Of Tune With Earnings

Beijing Wandong Medical TechnologyLtd's (SHSE:600055) Returns On Capital Not Reflecting Well On The Business

Jun 25
Beijing Wandong Medical TechnologyLtd's (SHSE:600055) Returns On Capital Not Reflecting Well On The Business

We Think You Should Be Aware Of Some Concerning Factors In Beijing Wandong Medical TechnologyLtd's (SHSE:600055) Earnings

May 03
We Think You Should Be Aware Of Some Concerning Factors In Beijing Wandong Medical TechnologyLtd's (SHSE:600055) Earnings

What Beijing Wandong Medical Technology Co.,Ltd.'s (SHSE:600055) 26% Share Price Gain Is Not Telling You

Mar 07
What Beijing Wandong Medical Technology Co.,Ltd.'s (SHSE:600055) 26% Share Price Gain Is Not Telling You

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Beijing Wandong Medical TechnologyLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SHSE:600055 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20241,404184143187N/A
6/30/20241,342197143186N/A
3/31/20241,290191148177N/A
12/31/20231,237189191208N/A
9/30/20231,314192143159N/A
6/30/20231,259192172188N/A
3/31/20231,166181150166N/A
12/31/20221,121175171185N/A
9/30/20221,08816688107N/A
6/30/20221,118159110126N/A
3/31/20221,12715994105N/A
12/31/20211,1561837890N/A
9/30/20211,196193357373N/A
6/30/20211,124199340360N/A
3/31/20211,122219345366N/A
12/31/20201,132221497520N/A
9/30/20201,082226367413N/A
6/30/20201,107230325366N/A
3/31/20201,071214283328N/A
12/31/20199821695395N/A
9/30/2019972156-240N/A
6/30/2019952155852N/A
3/31/20199821553573N/A
12/31/20189551533376N/A
9/30/2018968134-98-40N/A
6/30/2018933121N/A-105N/A
3/31/2018898110N/A-139N/A
12/31/2017884109N/A-78N/A
9/30/201778590N/A-20N/A
6/30/201776470N/A37N/A
3/31/201780883N/A97N/A
12/31/201681372N/A103N/A
9/30/201686060N/A63N/A
6/30/201685552N/A43N/A
3/31/201683251N/A44N/A
12/31/201581840N/A-16N/A
9/30/201581937N/A22N/A
6/30/201577935N/A18N/A
3/31/201576621N/A-1N/A
12/31/201474026N/A34N/A
9/30/201471839N/A52N/A
6/30/201473237N/A56N/A
3/31/201472627N/A31N/A
12/31/201376544N/A21N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 600055's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 600055's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 600055's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 600055's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 600055's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 600055's Return on Equity is forecast to be high in 3 years time


Discover growth companies